LAWRENCE ADJEI: Open Payments
NPI 1689637134 · RINCON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,272 in 115 payments from 24 companies in 2025. Trend: 2023 $3,052 · 2024 $2,601 · 2025 $2,272
Food & beverage: $2,272
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $335 |
| ABBVIE INC. | 19 | $323 |
| Novo Nordisk Inc | 17 | $282 |
| Axsome Therapeutics, Inc. | 11 | $255 |
| Novartis Pharmaceuticals Corporation | 7 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $118 |
| HARMONY BIOSCIENCES LLC | 4 | $89 |
| PFIZER INC. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| Insulet Corporation | 4 | $75 |
Products named: AIRSUPRA, Auvelity, VRAYLAR, QULIPTA, LEQVIO, CAPLYTA, Wegovy, REXULTI.
Industry payments across GA — which companies pay providers there.
